Ali Marian is a Cardiology physician affiliated with The University of Texas Health Science Center at Houston. OpenAlex indexes 327 publications with 19,263 citations (h-index 67); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6770 Bertner St
Dac900
Houston, TX 770302604
Telephone
713-500-2350Provider last certified this registry record 6 Apr 2026.
Clinical trials
- Hypertrophic Regression With N-Acetylcysteine in HCM
Sponsor: The University of Texas Health Science Center, Houston
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20241 payment
- Philips North America LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
9 NIH research awards on record, funded 2000–2026 per NIH RePORTER. The latest:
- Cytosolic DNA is the Link Between Genomic Instability and Cardiovascular Aging
University of Texas Hlth Sci Ctr Houston
FY2026$587,703R01AG082751 - Mechanisms and Therapeutic Targeting of DNA Damage in Dilated Cardiomyopathy Caused by LMNA Mutations
University of Texas Hlth Sci Ctr Houston
FY2026$568,920R01HL132401 - Mechanisms and Therapeutic Targeting of DNA Damage in Dilated Cardiomyopathy Caused by LMNA Mutations
University of Texas Hlth Sci Ctr Houston
FY2025$580,531R01HL132401
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Cardiovascular Research
2020 - Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy
Journal of the American College of Cardiology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Frank Arnett, MD
The University of Texas Health Science Center at Houston
Anjail Sharrief, MD
The University of Texas Health Science Center at Houston
Heidi Russell, MD
The University of Texas Health Science Center at Houston
Spiros Blackburn, MD
The University of Texas Health Science Center at Houston
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”